The calendar slowed down this past week, with only small listings in the US. One qualified for inclusion in our IPO stats. Diagnostics company Anbio Biotechnology (NNNN) priced at the low end to raise $8 million at a $219 million market cap. Headquartered in...read more
Anbio Biotechnology, a developer of in vitro diagnostics products, raised $8 million by offering 1.6 million shares at $5, the low end of the range of $5 to $6. The IPO float represents 3.6% of the total shares outstanding.Anbio is headquartered...read more
Two small IPOs listed this week. Four IPOs and two SPACs submitted initial filings.Chinese industrial machinery producer INLIF (INLF) priced at the bottom of the range to raise $8 million at a $58 million market cap. The company develops, manufactures, and...read more
Anbio Biotechnology, a Germany-based developer of in vitro diagnostics products, filed on Tuesday with the SEC to raise up to $9 million in an initial public offering.The Frankfurt am Main, Germany-based company plans to raise $9 million by offering 1.6 million ...read more
US IPO Weekly Recap: IPO calendar slows down with small listings
The calendar slowed down this past week, with only small listings in the US. One qualified for inclusion in our IPO stats. Diagnostics company Anbio Biotechnology (NNNN) priced at the low end to raise $8 million at a $219 million market cap. Headquartered in...read more
Diagnostics company Anbio Biotechnology prices US IPO at $5 low end
Anbio Biotechnology, a developer of in vitro diagnostics products, raised $8 million by offering 1.6 million shares at $5, the low end of the range of $5 to $6. The IPO float represents 3.6% of the total shares outstanding.Anbio is headquartered...read more
US IPO Weekly Recap: 2 microcaps list as more small issuers file for listings
Two small IPOs listed this week. Four IPOs and two SPACs submitted initial filings.Chinese industrial machinery producer INLIF (INLF) priced at the bottom of the range to raise $8 million at a $58 million market cap. The company develops, manufactures, and...read more
Germany-based diagnostics products developer Anbio Biotechnology files for a $9 million US IPO
Anbio Biotechnology, a Germany-based developer of in vitro diagnostics products, filed on Tuesday with the SEC to raise up to $9 million in an initial public offering.The Frankfurt am Main, Germany-based company plans to raise $9 million by offering 1.6 million ...read more